226 related articles for article (PubMed ID: 21753716)
1. Microglandular adenosis with transition to breast carcinoma: a series of three cases.
Lin L; Pathmanathan N
Pathology; 2011 Aug; 43(5):498-503. PubMed ID: 21753716
[No Abstract] [Full Text] [Related]
2. [Invasive carcinoma arising in breast microglandular adenosis: a clinicopathologic study of three cases and review of the literature].
Shui RH; Cheng YF; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2011 Jul; 40(7):471-4. PubMed ID: 22088374
[TBL] [Abstract][Full Text] [Related]
3. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
4. Massive myoepithelial proliferation (myoepitheliosis) with lumpy deposits of basement membrane material closely associated with apocrine adenosis and ductal carcinoma in situ of the breast.
Kawasaki T; Oyama T; Nakagomi H; Furuya K; Kondo T; Nakazawa T; Mochizuki K; Yamane T; Miyazawa T; Ishii Y; Fukushima K; Moriya T; Tsunoda H; Katoh R
Pathol Int; 2011 Oct; 61(10):615-7. PubMed ID: 21951673
[No Abstract] [Full Text] [Related]
5. Microglandular Adenosis: A Possible Non-Obligate Precursor to Breast Carcinoma With Potential to Either Luminal-Type or Basal-Type Differentiation.
Damron AT; Korhonen K; Zuckerman S; Tchou J; Dumoff KL; Bleiweiss IJ; Nayak A
Int J Surg Pathol; 2019 Oct; 27(7):781-787. PubMed ID: 31046496
[TBL] [Abstract][Full Text] [Related]
6. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
[TBL] [Abstract][Full Text] [Related]
7. Low-grade ductal carcinoma in situ and invasive mammary carcinoma with columnar cell morphology arising in a complex fibroadenoma in continuity with columnar cell change and flat epithelial atypia.
Petersson F; Tan PH; Putti TC
Int J Surg Pathol; 2010 Oct; 18(5):352-7. PubMed ID: 20643672
[TBL] [Abstract][Full Text] [Related]
8. Young-aged woman with invasive ductal carcinoma arising in atypical microglandular adenosis: a case report.
Lee YH; Dai YC; Lin IL; Tu CW
Pathol Int; 2010 Oct; 60(10):685-9. PubMed ID: 20846267
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of 14-3-3 sigma and related proteins in hyperplastic and neoplastic breast lesions, with particular reference to early carcinogenesis.
Simooka H; Oyama T; Sano T; Horiguchi J; Nakajima T
Pathol Int; 2004 Aug; 54(8):595-602. PubMed ID: 15260850
[TBL] [Abstract][Full Text] [Related]
10. Invasive breast carcinoma arising in microglandular adenosis: a case report and review of the literature.
Shui R; Yang W
Breast J; 2009; 15(6):653-6. PubMed ID: 19824997
[TBL] [Abstract][Full Text] [Related]
11. Differentiation between cancerous and normal hyperplastic lobules in breast lesions.
Slater M; Danieletto S; Pooley M; Cheng Teh L; Gidley-Baird A; Barden JA
Breast Cancer Res Treat; 2004 Jan; 83(1):1-10. PubMed ID: 14997049
[TBL] [Abstract][Full Text] [Related]
12. Ten-year follow-up of mammary carcinoma arising in microglandular adenosis treated with breast conservation.
Resetkova E; Flanders DJ; Rosen PP
Arch Pathol Lab Med; 2003 Jan; 127(1):77-80. PubMed ID: 12521372
[TBL] [Abstract][Full Text] [Related]
13. Breast carcinoma with chondroid differentiation: a clinicopathologic study of 21 triple negative (ER-, PR-, Her2/neu-) cases.
Gwin K; Wheeler DT; Bossuyt V; Tavassoli FA
Int J Surg Pathol; 2010 Feb; 18(1):27-35. PubMed ID: 19282292
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathologic features of cystic hypersecretory lesion of the breast].
Bi R; Cheng Y; Yu B; Shui R; Yang W; Xu X
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):25-9. PubMed ID: 24713245
[TBL] [Abstract][Full Text] [Related]
15. Microglandular adenosis is an advanced precursor breast lesion with evidence of molecular progression to matrix-producing metaplastic carcinoma.
Schwartz CJ; Dolgalev I; Yoon E; Osman I; Heguy A; Vega-Saenz de Miera EC; Nimeh D; Jour G; Darvishian F
Hum Pathol; 2019 Mar; 85():65-71. PubMed ID: 30428388
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of E-cadherin in sclerosing adenosis, ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Facina G; Lopes-Costa PV; Dos Santos AR; De Vasconcelos-Valença RJ; Pinho-Sobral AL; Ferreira-Filho CP; Alencar AP; Gebrim LH; Da Silva BB
Diagn Cytopathol; 2010 Apr; 38(4):235-8. PubMed ID: 19790246
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
[TBL] [Abstract][Full Text] [Related]
18. Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Xie F; Wang Q; Chen Y; Gu Y; Mao H; Zeng W; Zhang X
Pathol Res Pract; 2010 Nov; 206(11):735-9. PubMed ID: 20634005
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions.
Weinstat-Saslow D; Merino MJ; Manrow RE; Lawrence JA; Bluth RF; Wittenbel KD; Simpson JF; Page DL; Steeg PS
Nat Med; 1995 Dec; 1(12):1257-60. PubMed ID: 7489405
[TBL] [Abstract][Full Text] [Related]
20. [Cystic hypersecretory carcinoma with microinvasive carcinoma and cystic hypersecretory hyperplasia of breast: report of a case].
Chen DB; Kan X
Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):54-5. PubMed ID: 20388402
[No Abstract] [Full Text] [Related]
[Next] [New Search]
